Marc Hedrick
Amministratore Delegato presso PLUS THERAPEUTICS, INC.
Patrimonio netto: 27 537 $ in data 31/05/2024
Posizioni attive di Marc Hedrick
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | Amministratore Delegato | 02/04/2014 | - |
| Direttore/Membro del Consiglio | 01/10/2002 | - | |
| Presidente | 01/10/2002 | - | |
| Comptroller/Controller/Auditor | 09/08/2019 | 06/11/2019 | |
| Direttore Finanziario/CFO | 11/08/2014 | 02/09/2014 |
Storia della carriera di Marc Hedrick
Precedenti posizioni note di Marc Hedrick
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MacroPore Biosurgery, Inc. /Old/ | Direttore Tecnico/Scientifico/R&S | 01/01/2002 | 01/01/2004 |
StemSource, Inc.
 StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Plus Therapeutics, Inc., StemSource, Inc. develops treatments for cancer. The company is based in Thousand Oaks, CA. The company was founded by Adam J. Katz, Marc H. Hedrick. StemSource was acquired by MacroPore Biosurgery, Inc. on November 30, 2002 for $5.71 million. | Direttore/Membro del Consiglio | - | 01/01/2003 |
| Amministratore Delegato | 01/01/2001 | 01/01/2003 | |
| Fondatore | 01/12/2000 | 01/01/2003 | |
| Presidente | 01/01/2001 | 01/01/2003 | |
| UCLA Anderson School of Management | Corporate Officer/Principal | - | - |
| University of California, Los Angeles | Corporate Officer/Principal | - | - |
Cytori Therapeutics, Inc. (JP)
 Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Cytori Therapeutics KK engages in the manufacture, import, export and sales of medical devices. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
| Presidente | - | - | |
Cytori Ltd.
 Cytori Ltd. Pharmaceuticals: OtherHealth Technology Cytori Ltd. develops biological products. The company was founded on February 7, 2014 and is headquartered in Deeside, the United Kingdom. | Direttore/Membro del Consiglio | 07/02/2014 | - |
Formazione di Marc Hedrick
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Regno Unito | 2 |
| Giappone | 2 |
Posizioni
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Settori
| Health Technology | 5 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PLUS THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
| MacroPore Biosurgery, Inc. /Old/ | Health Technology |
StemSource, Inc.
StemSource, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Plus Therapeutics, Inc., StemSource, Inc. develops treatments for cancer. The company is based in Thousand Oaks, CA. The company was founded by Adam J. Katz, Marc H. Hedrick. StemSource was acquired by MacroPore Biosurgery, Inc. on November 30, 2002 for $5.71 million. | Commercial Services |
Cytori Ltd.
Cytori Ltd. Pharmaceuticals: OtherHealth Technology Cytori Ltd. develops biological products. The company was founded on February 7, 2014 and is headquartered in Deeside, the United Kingdom. | Health Technology |
Cytori Therapeutics, Inc. (JP)
Cytori Therapeutics, Inc. (JP) BiotechnologyHealth Technology Cytori Therapeutics KK engages in the manufacture, import, export and sales of medical devices. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Marc Hedrick
- Esperienza
